Sichuan Meifeng Chemical Industry Co., Ltd. (SHE:000731)
China · Delayed Price · Currency is CNY 6.33
+0.06 (0.96%)
May 22, 2026, 3:04 PM CST
SHE:000731 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,609 | 3,638 | 4,493 | 4,102 | 4,824 | 4,027 |
Other Revenue | 76.69 | 76.69 | 61.49 | 72.32 | 85.48 | 64.27 |
| 3,685 | 3,715 | 4,554 | 4,174 | 4,910 | 4,091 | |
Revenue Growth (YoY) | -19.94% | -18.43% | 9.10% | -14.98% | 20.01% | 40.47% |
Cost of Revenue | 3,419 | 3,430 | 3,740 | 3,331 | 3,693 | 2,950 |
Gross Profit | 266.59 | 284.95 | 814.58 | 842.9 | 1,217 | 1,141 |
Selling, General & Admin | 341.78 | 340.98 | 410.39 | 401.34 | 355.56 | 339.88 |
Research & Development | 41.86 | 45.03 | 29.5 | 15.23 | 9.56 | 8.68 |
Other Operating Expenses | 31.52 | 40.06 | 105.19 | 32.65 | 38.43 | 36.31 |
Operating Expenses | 409.97 | 419.96 | 541.52 | 432.71 | 407.1 | 397.78 |
Operating Income | -143.38 | -135.01 | 273.06 | 410.2 | 809.58 | 743.13 |
Interest Expense | -6.61 | -7.78 | -8.32 | -0.34 | -7.81 | -15.37 |
Interest & Investment Income | 31.57 | 36.17 | 97.77 | 59.33 | 61.28 | 41.45 |
Currency Exchange Gain (Loss) | -1.03 | -1.03 | 0.01 | -0.85 | 2.41 | -0.97 |
Other Non Operating Income (Expenses) | -0.94 | 0.14 | -0.85 | -0.73 | -0.6 | 0.05 |
EBT Excluding Unusual Items | -120.4 | -107.51 | 361.67 | 467.6 | 864.87 | 768.29 |
Gain (Loss) on Sale of Investments | - | - | -17.43 | - | - | - |
Gain (Loss) on Sale of Assets | -2.16 | -1.95 | 1.55 | 23.37 | 10.91 | 5.07 |
Asset Writedown | -12.96 | -12.96 | -9.24 | -1.2 | -22.07 | -39.42 |
Other Unusual Items | 11.37 | 10.07 | 5.79 | 8.71 | 12.39 | 6.76 |
Pretax Income | -124.14 | -112.34 | 342.33 | 498.48 | 866.1 | 740.7 |
Income Tax Expense | 11.67 | 8.48 | 57.19 | 88.99 | 130.93 | 81.88 |
Earnings From Continuing Operations | -135.82 | -120.82 | 285.14 | 409.48 | 735.17 | 658.81 |
Minority Interest in Earnings | -5.84 | -1.09 | -13.4 | -26.91 | -113.1 | -89.87 |
Net Income | -141.65 | -121.91 | 271.74 | 382.58 | 622.08 | 568.95 |
Net Income to Common | -141.65 | -121.91 | 271.74 | 382.58 | 622.08 | 568.95 |
Net Income Growth | - | - | -28.97% | -38.50% | 9.34% | 448.60% |
Shares Outstanding (Basic) | 553 | 556 | 567 | 580 | 586 | 590 |
Shares Outstanding (Diluted) | 553 | 556 | 567 | 580 | 586 | 590 |
Shares Change (YoY) | -1.86% | -2.03% | -2.27% | -0.91% | -0.74% | -0.26% |
EPS (Basic) | -0.26 | -0.22 | 0.48 | 0.66 | 1.06 | 0.96 |
EPS (Diluted) | -0.26 | -0.22 | 0.48 | 0.66 | 1.06 | 0.96 |
EPS Growth | - | - | -27.32% | -37.93% | 10.15% | 450.03% |
Free Cash Flow | -56.48 | 11.58 | 333.59 | 218.02 | 824.84 | 608.38 |
Free Cash Flow Per Share | -0.10 | 0.02 | 0.59 | 0.38 | 1.41 | 1.03 |
Dividend Per Share | 0.100 | 0.100 | 0.270 | 0.170 | 0.170 | 0.170 |
Dividend Growth | -62.96% | -62.96% | 58.68% | 0.09% | - | - |
Gross Margin | 7.23% | 7.67% | 17.89% | 20.19% | 24.78% | 27.89% |
Operating Margin | -3.89% | -3.63% | 6.00% | 9.83% | 16.49% | 18.16% |
Profit Margin | -3.84% | -3.28% | 5.97% | 9.16% | 12.67% | 13.91% |
Free Cash Flow Margin | -1.53% | 0.31% | 7.32% | 5.22% | 16.80% | 14.87% |
EBITDA | 74.67 | 82.51 | 488.46 | 626.47 | 1,012 | 948.21 |
EBITDA Margin | 2.03% | 2.22% | 10.73% | 15.01% | 20.61% | 23.18% |
D&A For EBITDA | 218.05 | 217.52 | 215.4 | 216.28 | 202.09 | 205.07 |
EBIT | -143.38 | -135.01 | 273.06 | 410.2 | 809.58 | 743.13 |
EBIT Margin | -3.89% | -3.63% | 6.00% | 9.83% | 16.49% | 18.16% |
Effective Tax Rate | - | - | 16.71% | 17.85% | 15.12% | 11.05% |
Revenue as Reported | 3,685 | 3,715 | 4,554 | 4,174 | 4,910 | 4,091 |
Advertising Expenses | - | 3.58 | 9.85 | 12.58 | 6.53 | 7.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.